OpenURL Connection Search

Select item for more details and to access through your institution.

Next-generation CAR T cell therapies for glioblastoma.
Published in:
Science Translational Medicine, 2024, v. 16, n. 762, p. 1, doi. 10.1126/scitranslmed.adp2660
By:
- Bernstock, Joshua D.;
- Gerstl, Jakob V. E.;
- Valdés, Pablo A.;
- Friedman, Gregory K.;
- Chiocca, Antonio
Publication type:
Article
An autoimmune transcriptional circuit drives FOXP3<sup>+</sup> regulatory T cell dysfunction.
Published in:
Science Translational Medicine, 2024, v. 16, n. 762, p. 1, doi. 10.1126/scitranslmed.adp1720
By:
- Sumida, Tomokazu S.;
- Lincoln, Matthew R.;
- He, Liang;
- Park, Yongjin;
- Ota, Mineto;
- Oguchi, Akiko;
- Son, Raku;
- Yi, Alice;
- Stillwell, Helen A.;
- Leissa, Greta A.;
- Fujio, Keishi;
- Murakawa, Yasuhiro;
- Kulminski, Alexander M.;
- Epstein, Charles B.;
- Bernstein, Bradley E.;
- Kellis, Manolis;
- Hafler, David A.
Publication type:
Article
Activation and antitumor immunity of CD8<sup>+</sup> T cells are supported by the glucose transporter GLUT10 and disrupted by lactic acid.
Published in:
Science Translational Medicine, 2024, v. 16, n. 762, p. 1, doi. 10.1126/scitranslmed.adk7399
By:
- Liu, Ying;
- Wang, Feng;
- Peng, Dongxue;
- Zhang, Dan;
- Liu, Luping;
- Wei, Jun;
- Yuan, Jian;
- Zhao, Luyao;
- Jiang, Huimin;
- Zhang, Tingting;
- Li, Yunxuan;
- Zhao, Chenxi;
- He, Shuhua;
- Wu, Jie;
- Yan, Yechao;
- Zhang, Peitao;
- Guo, Chunyi;
- Zhang, Jiaming;
- Li, Xia;
- Gao, Huan
Publication type:
Article
Inhibiting endothelial Rhoj blocks profibrotic vascular intussusception and angiocrine factors to sustain lung regeneration.
Published in:
Science Translational Medicine, 2024, v. 16, n. 762, p. 1, doi. 10.1126/scitranslmed.ado5266
By:
- Ma, Jie;
- Zhang, Liyin;
- Zhang, Xu;
- Zhang, Lanlan;
- Zhang, Hua;
- Zhu, Yulei;
- Huang, Xingming;
- Zhang, Ting;
- Tang, Xiangdong;
- Wang, Yuan;
- Chen, Lu;
- Pu, Qiang;
- Yang, Liming;
- Cao, Zhongwei;
- Ding, Bi-Sen
Publication type:
Article
Nanoparticle delivery of innate immune agonists combined with senescence-inducing agents promotes T cell control of pancreatic cancer.
Published in:
Science Translational Medicine, 2024, v. 16, n. 762, p. 1, doi. 10.1126/scitranslmed.adj9366
By:
- Chibaya, Loretah;
- DeMarco, Kelly D.;
- Lusi, Christina F.;
- Kane, Griffin I.;
- Brassil, Meghan L.;
- Parikh, Chaitanya N.;
- Murphy, Katherine C.;
- Chowdhury, Shreya R.;
- Li, Junhui;
- Ma, Boyang;
- Naylor, Tiana E.;
- Cerrutti, Julia;
- Mori, Haruka;
- Diaz-Infante, Miranda;
- Peura, Jessica;
- Pitarresi, Jason R.;
- Zhu, Lihua Julie;
- Fitzgerald, Katherine A.;
- Atukorale, Prabhani U.;
- Ruscetti, Marcus
Publication type:
Article

Found: 5

Next-generation CAR T cell therapies for glioblastoma.

An autoimmune transcriptional circuit drives FOXP3<sup>+</sup> regulatory T cell dysfunction.

Activation and antitumor immunity of CD8<sup>+</sup> T cells are supported by the glucose transporter GLUT10 and disrupted by lactic acid.

Inhibiting endothelial Rhoj blocks profibrotic vascular intussusception and angiocrine factors to sustain lung regeneration.

Nanoparticle delivery of innate immune agonists combined with senescence-inducing agents promotes T cell control of pancreatic cancer.